Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
about
5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstructionPhosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasiaTadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of actionPhosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive reviewEfficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptomsUdenafil for the treatment of erectile dysfunctionThe new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase-5 inhibitorsAge-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progressionRetrograde ejaculation, painful ejaculation and hematospermiaEjaculatory dysfunction in the treatment of lower urinary tract symptomsCustom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data.A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW).Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controllLower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment.Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sampleEffect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction.A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionSexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.Alpha-blocker use is associated with decreased risk of sexual dysfunction.Combination therapy for erectile dysfunction: an update review.Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health SurveyOral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study.Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study GroupProgression of lower urinary tract symptoms in older men: a community based study.The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study.A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual menObstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle.Serial Changes in Sexual Function Following Holmium Laser Enucleation of the Prostate: A Short-term Follow-up Study.A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing networkClinical correlates of enlarged prostate size in subjects with sexual dysfunction
P2860
Q24188312-1C73C359-192E-404A-A878-C8976DDBDBC3Q24199135-E5B30CAE-6BC7-494F-B270-79033BED3831Q26783529-5BF567E6-7B4B-49AE-A1B2-76107DBA1F16Q26785752-34583E18-EFC6-45AD-9D29-65F4F74F3F69Q26825032-29F2E241-021D-4E1B-B52E-E63F52AB4690Q26851999-267A07B3-9C2F-4320-8315-B71EA3BA21F1Q27025700-B69ADF4F-DE66-4A28-A041-3E4D37029E09Q27027373-A64CF54C-3D0D-4A0D-AF27-72A0F52DA75FQ28071742-8EE25059-FF05-444E-A2E0-6DA8838263DDQ28073775-D47D2070-737B-4875-BC2D-95DA0863B6ADQ28547212-A874661F-ED57-42FF-B0BC-EA9D028B253FQ30373008-ED2B7325-6C4A-4517-8308-ED2984088BCFQ30432283-3F601E58-D423-4664-B52F-38593B93C093Q30574070-2C465C2B-E099-428A-B573-6741B718070FQ30764782-2DA2AC18-0AF8-4DD7-92A5-F55E3D5E5A95Q30987913-08C10CB0-7D12-4FC6-9E89-46D461B9C04BQ30989621-2B82FBFA-4F17-4BD3-B280-91ACAD8CDD87Q31149807-EDE7909F-6E13-4431-9D84-F7F6B4C3E9A8Q33289952-833E196E-60CB-4D01-931D-6472342AF289Q33578216-40E4F180-41B3-4F09-8463-98B669B19E16Q33692658-F57108CA-C1B5-4EDA-B842-7A6347D4D90CQ33744285-506B7B0D-176A-449D-9649-57BADE574B6EQ33817942-4AFF6545-68BF-488D-88FE-1F14A79BEEDEQ33822355-331FD076-9929-48EF-B2B3-3C4321650A1DQ33822420-6C52372F-4F43-4A01-A0D8-67D84C594E23Q33851191-5C5F64C9-DE70-471E-9008-56D9FBF2520BQ33871847-40183803-CB2E-413C-AE2C-13A607F0692DQ33880138-E362B4B3-7ED9-44A5-8288-2B62057C14F5Q33888517-2C475A87-7F7D-4132-BD33-0424D330188DQ33958191-215AAF4C-5F97-4543-A40D-F03C3725855EQ34006676-633A970A-A7EC-432C-B5C8-75885ADAFC06Q34009467-47763D85-877D-4511-B296-FEB657AC59BFQ34038361-CAE91217-A7D2-4010-829F-E85278867744Q34062449-C99E56AE-54B5-4923-8BBE-410DABBFB748Q34112983-C4919454-363F-4F1B-8B1D-3A31D06F50D1Q34179769-A00C5728-31FE-45D3-8B67-3D0440A04EF0Q34181927-B15388F2-2CAD-4BD9-8789-706F6E969926Q34196420-872E6879-A977-43DE-8274-62A76183AC27Q34328954-0FB89CD4-00F4-4A6E-BB53-FC0923632EEEQ34433316-25FEABE2-E0FA-445A-BF05-DEFCC03BB778
P2860
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Lower urinary tract symptoms a ...... ey of the aging male (MSAM-7).
@en
Lower urinary tract symptoms a ...... ional survey of the aging male
@nl
type
label
Lower urinary tract symptoms a ...... ey of the aging male (MSAM-7).
@en
Lower urinary tract symptoms a ...... ional survey of the aging male
@nl
prefLabel
Lower urinary tract symptoms a ...... ey of the aging male (MSAM-7).
@en
Lower urinary tract symptoms a ...... ional survey of the aging male
@nl
P2093
P1433
P1476
Lower urinary tract symptoms a ...... ey of the aging male (MSAM-7).
@en
P2093
Chris Robertson
Eric Meuleman
Francois Giuliano
Jens Altwein
Michael P O'Leary
Paolo Puppo
Raymond Rosen
Roger S Kirby
P304
P356
10.1016/J.EURURO.2003.08.015
P407
P50
P577
2003-12-01T00:00:00Z